Evaluation of mirna-371a-3p (mir371a) assay to predict final pathohistology in patients undergoing primary nerve-sparing retroperitoneal lymphadenectomy (nsrplnd) for stage iia/bseminomas andnon-seminomas
JOURNAL OF UROLOGY（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要